Skip to main content

Advertisement

Table 3 mini-RQLQ scores by country and ARIA severity

From: Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort survey

  Total FF MF FP
  N Mean (SD) N Mean (SD) N β 95% CI N β 95% CI
Mini-RQLQ score 429 1.54 (1.06) 217 1.42 (1.04) 98 0.28 0.03 to 0.52 114 0.18 −0.05 to 0.41
Country sub-groups:           
  France 155 1.35 (0.98) 79 1.25 (1.02) 33 0.46 0.09 to 0.83* 43 0.13 −0.22 to 0.48
  Germany 170 1.57 (0.97) 86 1.48 (0.98) 42 0.12 −0.25 to 0.48 42 0.17 −0.20 to 0.54
  Spain 104 1.75 (1.27) 52 1.57 (1.16) 23 0.08 −0.51 to 0.66 29 0.06 −0.50 to 0.63
Severity sub-groups:           
  Mild intermittent 52 0.89 (0.80) 28 0.92 (0.89) 9 −0.01 −0.71 to 0.69 15 −0.21 −0.83 to 0.40
  Moderate/severe intermittent 143 1.41 (0.98) 78 1.35 (1.01) 37 0.09 −0.28 to 0.46 28 0.24 −0.18 to 0.65
  Moderate/severe persistent 234 1.76 (1.09) 111 1.59 (1.06) 52 0.45 0.09 to 0.81* 71 0.22 −0.11 to 0.55
  1. FF: Fluticasone furoate; FP: Fluticasone propionate; MF: Mometasone furoate; β = adjusted mean difference from FF.
  2. *p<0.05 (Bonferroni correction applied).